文献速递腹部CTMR

低剂量平扫CT迭代重建对胰腺病变的可检测性

Detectability of pancreatic lesions by low-dose unenhanced computed tomography using iterative reconstruction.
PubMed 文献 · Eur J Radiol · 2021-05-15

本研究纳入2684例健康筛查者,评估低剂量平扫CT迭代重建对胰腺囊性病变和主胰管扩张的检出率,以MRI为参考标准。结果显示1-9mm囊肿检出率仅0.65%,10-19mm为21.25%,≥20mm为47.06%;3-5mm主胰管扩张检出率11.76%,≥6mm为80%。结论认为低剂量平扫CT不宜作为胰腺病变筛查工具。

要点

  • 低剂量平扫CT对1-9mm胰腺囊肿几乎无法检出,检出率仅0.65%。
  • 囊肿≥10mm时检出率仍低(10-19mm为21.25%,≥20mm为47.06%)。
  • 主胰管扩张3-5mm检出率仅11.76%,≥6mm可达80%。

核心结论

  • 小的胰腺囊肿和轻度主胰管扩张在低剂量平扫CT上实际无法检出。
  • 不推荐将低剂量平扫CT方案作为检测胰腺异常的筛查工具。

研究设计与样本

  • 以MRI为参考标准识别胰腺囊性病变和/或主胰管扩张,比较低剂量CT检出率。

诊断标准与关键数值

  • 胰腺囊性病变低剂量CT检出率:1-9mm为0.65%(3/461),10-19mm为21.25%(17/80),≥20mm为47.06%(8/17);10-19mm和≥20mm组检出率显著高于1-9mm组(p<0.001)。
  • 主胰管扩张低剂量CT检出率:3-5mm为11.76%(2/17),≥6mm为80%(4/5);≥6mm组检出率显著高于3-5mm组(p=0.009)。

临床应用与阅片要点

  • 在日常阅片中,对低剂量平扫CT上可疑的胰腺小囊肿或轻度主胰管扩张应谨慎解释,必要时建议MRI进一步评估。
  • 不应将低剂量平扫CT作为胰腺病变的筛查手段,尤其对小于10mm的囊性病变和小于6mm的主胰管扩张。

局限性

  • 单中心回顾性研究,仅纳入健康筛查人群,结果外推需谨慎。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

英文原文(摘要)· 点击展开

OBJECTIVES: To investigate the detectability of pancreatic cystic lesions and main pancreatic duct dilation by low-dose unenhanced computed tomography (CT).

MATERIAL AND METHODS: This study included 2684 patients who underwent low-dose unenhanced CT using iterative reconstruction and magnetic resonance imaging (MRI) as a part of a health-screening program between February 1, 2019 and December 31, 2019. Patients diagnosed with pancreatic cystic lesions and/or dilatations of the main pancreatic duct on MRI were identified. Detection rates by low dose CT in terms of lesion size were tested for significance by Fisher's exact test.

RESULTS: Of the 2684 patients, 558 (20.8 %) had pancreatic cystic lesions and 22 (0.8 %) had main pancreatic duct dilatation on MRI. The low-dose CT detection rates among the pancreatic cystic lesions were as follows: 1-9-mm cysts, three (0.65 %) of 461; 10-19-mm cysts, 17 (21.25 %) of 80, and ≥20-mm cysts, eight (47.06 %) of 17. The detection rates were significantly higher in the 10-19-mm and the ≥20-mm cyst group than in the 1-9-mm cyst group (p < 0.001). The detection rates among the main pancreatic duct dilatations were as follows: 3-5-mm dilatations, two (11.76 %) of 17 and ≥6-mm dilatations, four (80 %) of five, which were significantly higher rates than that for the 3-5-mm dilatations (p = 0.009).

CONCLUSION: Small pancreatic cysts and slight main pancreatic duct dilatation were practically undetectable by low-dose unenhanced CT. The application of a low-dose CT protocol as a screening tool in the detection of pancreatic abnormalities is not recommended.

来源:Eur J Radiol,查看原文。版权归原作者所有。

引用

  1. Sugawara H, Yoshikawa T, Kunimatsu A, et al. Detectability of pancreatic lesions by low-dose unenhanced computed tomography using iterative reconstruction. Eur J Radiol. 2021. PMID: 34029934. doi:10.1016/j.ejrad.2021.109776

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。